ETHOCEL provides formulation flexibility for pharmaceutical applications:
- Range of molecular weights, can be blended for intermediate viscosities
- Fine particle (FP) range for use in inert matrix systems, providing improved lipophilic properties realized by increase in surface area
- Modify release profiles when ETHOCEL is used in combination with water-soluble excipients, such as METHOCEL™ premium cellulose ethers
ETHOCEL has been widely used in the Pharmaceutical industry for over 50 years, backed by an excellent safety record with global compendial acceptance and compliance with the US Food Chemical Codex. Also approved for dietary supplement use in Europe and USA.
Dow ETHOCEL™ Literature
Colorcon, through the Controlled Release Alliance, has exclusive, global sales and distribution rights for METHOCEL products from Dow Pharma & Food Solutions for use in controlled release applications.